Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exscientia Ltd ADR (EXAI)

Exscientia Ltd ADR (EXAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 632,927
  • Shares Outstanding, K 130,770
  • Annual Sales, $ 24,980 K
  • Annual Income, $ -181,560 K
  • EBIT $ -213 M
  • EBITDA $ -198 M
  • 60-Month Beta 0.83
  • Price/Sales 23.96
  • Price/Cash Flow N/A
  • Price/Book 1.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.51
  • Most Recent Earnings $-0.52 on 11/08/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +69.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.45 +8.76%
on 11/18/24
6.49 -25.42%
on 11/11/24
-0.37 (-7.10%)
since 10/18/24
3-Month
4.45 +8.76%
on 11/18/24
6.49 -25.42%
on 11/11/24
-0.65 (-11.84%)
since 08/19/24
52-Week
3.80 +27.37%
on 08/05/24
7.91 -38.81%
on 02/12/24
-1.26 (-20.66%)
since 11/17/23

Most Recent Stories

More News
Expert.ai Presents EIX-Customer Screening for Intelligent Adverse News Monitoring in the Financial Sector

New solution builds on deep expertise with leading banks and financial institutions to strengthen anti-money laundering and compliance efforts

IM : 38.89 (+0.03%)
EXAI : 4.84 (+3.20%)
Expert.ai Strengthens Its Offering for the Insurance Industry with Advanced AI Solutions

Hybrid AI solutions showcased at ITC Vegas 2025 highlight new capabilities that streamline underwriting, claims and policy servicing for insurers.

EXAI : 4.84 (+3.20%)
Expert.ai Introduces New AI Solutions to Accelerate Pharma & Life Sciences Innovation

Unveiled at BioTechX Europe 2025, the new solutions are purpose-built to accelerate research, clinical trial design and regulatory processes.

EXAI : 4.84 (+3.20%)
Expert.ai Recognized for AI Excellence for Insurance Solutions in Annual InsurTech100 List

ROCKVILLE, Md. , Sept. 30, 2025 /PRNewswire/ --  Expert.ai , a leading provider of enterprise artificial intelligence solutions for business value creation, has been named to the...

EXAI : 4.84 (+3.20%)
Expert.ai and Springer Nature Partner to Transform Clinical Trials with AI-Driven Intelligence and Deep Domain Expertise

Strategic collaboration sets a new standard for accelerating drug development through AI-driven insights.

EXAI : 4.84 (+3.20%)
Expert.ai Launches Enhanced Solutions for Digital Information Services

New solutions to debut at the Online News Association annual conference to showcase the latest digital trends and connect with journalists, leaders and technology innovators shaping the future of media....

EXAI : 4.84 (+3.20%)
NVIDIA Invested in These 2 AI Stocks, Should You?

Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution.

SERV : 13.42 (+3.23%)
NVDA : 182.41 (-0.53%)
OUST : 24.78 (-4.66%)
MGA : 49.03 (+0.16%)
SHAK : 78.03 (-2.61%)
RXRX : 4.71 (-4.27%)
EXAI : 4.84 (+3.20%)
RHHBY : 48.5200 (+0.66%)
CMG : 33.94 (-0.61%)
UBER : 91.32 (+0.36%)
SNY : 49.53 (+1.29%)
Inside the AI-Healthcare Boom: Breakthroughs in Diagnostics and Personalized Treatment

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...

MSFT : 483.16 (+0.48%)
NVDA : 182.41 (-0.53%)
TWST : 32.30 (-1.55%)
AVAI : 0.2875 (-2.58%)
ABSI : 3.58 (-4.02%)
RXRX : 4.71 (-4.27%)
EXAI : 4.84 (+3.20%)
1 AI Biotech Stock That Just Scored a Major Milestone

Down over 85% from all-time highs, Recursion Pharmaceuticals is an AI-powered biotech company that aims to accelerate the drug discovery process.

BAYZF : 38.7000 (-2.74%)
RXRX : 4.71 (-4.27%)
EXAI : 4.84 (+3.20%)
SNY : 49.53 (+1.29%)
AI in Healthcare Set for Explosive Growth with Projections Hitting $613 Billion by 2034

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI)...

BLFY : 11.97 (unch)
AVAI : 0.2875 (-2.58%)
GEHC : 85.46 (+3.56%)
RXRX : 4.71 (-4.27%)
EXAI : 4.84 (+3.20%)

Business Summary

Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.

See More

Key Turning Points

3rd Resistance Point 5.33
2nd Resistance Point 5.09
1st Resistance Point 4.97
Last Price 4.84
1st Support Level 4.60
2nd Support Level 4.36
3rd Support Level 4.24

See More

52-Week High 7.91
Fibonacci 61.8% 6.34
Fibonacci 50% 5.86
Fibonacci 38.2% 5.37
Last Price 4.84
52-Week Low 3.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar